featured
Increased Rates of Arterial Events, VTE, Thrombocytopenia, and Bleeding After Vaccination With Oxford–AstraZeneca ChAdOx1-S in Denmark and Norway
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
BMJ: British Medical Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Arterial Events, Venous Thromboembolism, Thrombocytopenia, and Bleeding After Vaccination With Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: Population Based Cohort Study
BMJ 2021 May 05;373(xx)n1114, A Pottegård, LC Lund, Ø Karlstad, J Dahl, M Andersen, J Hallas, Ø Lidegaard, G Tapia, HL Gulseth, PL Ruiz, SV Watle, AP Mikkelsen, L Pedersen, HT Sørensen, RW Thomsen, A HviidFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.